Assessment of major gaps from the perspective of patients, patient advocates and NET health care professionals.
Due to the increasing incidence and prevalence of neuroendocrine tumors (NETs), there is a need to assess any gaps in awareness and care. A survey was undertaken in 2017 to identify perceived unmet needs from the perspectives of patients/families, patient advocates and health care professionals (HCPs). The survey consisted of 33–37 questions (depending on type of respondent) across four areas: information, care, treatments and research.
Recent News
Complementary Therapies and Cancer Virtual Workshop
💻 VIRTUAL WORKSHOP - Complementary Therapies and Cancer. 🗓️ Tuesday 8th June 2021 | ⏰2.00pm-3:00pm ➡️ Run by the Cancer Rehab Team, Royal Berkshire NHS Foundation Trust. The session is held virtually via Microsoft Teams. The link to join the call is below; please...
World Digestive Health Day
Every 29th May, the World Gastroenterology Organisation (WGO) celebrates World Digestive Health Day (WDHD). Each year focuses upon a particular digestive disease and/or disorder in order to increase general public awareness of prevention, prevalence, diagnosis,...
Merkel Cell Carcinoma (MCC) Skin Cancer
Neuroendocrine Cancer UK is supporting Skin Cancer Awareness Month. Merkel cell carcinoma (MCC) is a rare, highly aggressive skin cancer, primarily affecting older patients, and thought to arise from the cutaneous Merkel cell, a neuroendocrine cell. The exact cause of...